|
|
|
Insider
Information: |
Van Oene Mark |
Relationship: |
See Remarks |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
1,685,401 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$4,834,062 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
1,685,401 |
|
|
Total
Value |
$4,834,062 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
7
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
7
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-7.0
|
Percentage
Gain/Loss : |
0.0%
|
-372.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Illumina Inc |
ILMN |
SVP Chief Commercial O... |
2020-11-05 |
16,575 |
|
0 |
Premium* |
|
Pacific Biosciences Of Californi... |
PACB |
See Remarks |
2024-03-04 |
1,668,826 |
2021-01-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
50 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ILMN |
Illumina Inc |
SVP Chief Commercial Officer |
|
2020-02-05 |
4 |
AS |
$300.24 |
$187,650 |
D/D |
(625) |
10,623 |
0 |
% |
|
ILMN |
Illumina Inc |
SVP Chief Commercial Officer |
|
2020-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,081 |
12,704 |
0 |
- |
|
ILMN |
Illumina Inc |
SVP Chief Commercial Officer |
|
2020-02-11 |
4 |
D |
$296.00 |
$2,415,656 |
D/D |
(8,161) |
22,005 |
0 |
- |
|
ILMN |
Illumina Inc |
SVP Chief Commercial Officer |
|
2020-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
5,821 |
26,735 |
0 |
- |
|
ILMN |
Illumina Inc |
SVP Chief Commercial Officer |
|
2020-02-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,641 |
30,166 |
0 |
- |
|
ILMN |
Illumina Inc |
SVP Chief Commercial Officer |
|
2020-04-16 |
4 |
AS |
$300.22 |
$375,275 |
D/D |
(1,250) |
20,755 |
0 |
% |
|
ILMN |
Illumina Inc |
SVP Chief Commercial Officer |
|
2020-05-01 |
4 |
AS |
$316.82 |
$198,016 |
D/D |
(625) |
20,130 |
0 |
% |
|
ILMN |
Illumina Inc |
SVP Chief Commercial Officer |
|
2020-06-01 |
4 |
AS |
$361.44 |
$225,963 |
D/D |
(625) |
19,505 |
0 |
% |
|
ILMN |
Illumina Inc |
SVP Chief Commercial Officer |
|
2020-07-01 |
4 |
AS |
$367.68 |
$230,874 |
D/D |
(625) |
18,880 |
0 |
% |
|
ILMN |
Illumina Inc |
SVP Chief Commercial Officer |
|
2020-08-03 |
4 |
AS |
$385.43 |
$240,894 |
D/D |
(625) |
18,255 |
0 |
% |
|
ILMN |
Illumina Inc |
SVP Chief Commercial Officer |
|
2020-09-01 |
4 |
AS |
$355.04 |
$221,953 |
D/D |
(625) |
17,648 |
0 |
% |
|
ILMN |
Illumina Inc |
SVP Chief Commercial Officer |
|
2020-11-05 |
4 |
D |
$311.72 |
$334,476 |
D/D |
(1,073) |
16,575 |
0 |
- |
|
PACB |
Pacific Biosciences Of Ca... |
Chief Operating Officer |
|
2021-01-08 |
4 |
A |
$0.00 |
$0 |
D/D |
335,000 |
335,000 |
0 |
- |
|
PACB |
Pacific Biosciences Of Ca... |
Chief Operating Officer |
|
2022-01-11 |
4 |
S |
$14.23 |
$590,260 |
D/D |
(41,480) |
293,520 |
0 |
% |
|
PACB |
Pacific Biosciences Of Ca... |
See Remarks |
|
2022-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
72,500 |
366,020 |
0 |
- |
|
PACB |
Pacific Biosciences Of Ca... |
See Remarks |
|
2022-08-25 |
4 |
A |
$0.00 |
$0 |
D/D |
300,000 |
667,528 |
0 |
- |
|
PACB |
Pacific Biosciences Of Ca... |
See Remarks |
|
2023-01-10 |
4 |
S |
$9.53 |
$254,768 |
D/D |
(26,722) |
640,808 |
0 |
% |
|
PACB |
Pacific Biosciences Of Ca... |
See Remarks |
|
2023-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
328,500 |
972,139 |
0 |
- |
|
PACB |
Pacific Biosciences Of Ca... |
See Remarks |
|
2023-03-03 |
4 |
S |
$9.49 |
$59,502 |
D/D |
(6,268) |
965,871 |
0 |
% |
|
PACB |
Pacific Biosciences Of Ca... |
See Remarks |
|
2023-08-16 |
4 |
S |
$11.00 |
$287,122 |
D/D |
(26,102) |
939,769 |
0 |
% |
|
PACB |
Pacific Biosciences Of Ca... |
See Remarks |
|
2024-01-09 |
4 |
S |
$7.77 |
$241,056 |
D/D |
(31,012) |
910,171 |
0 |
% |
|
PACB |
Pacific Biosciences Of Ca... |
See Remarks |
|
2024-02-16 |
4 |
S |
$5.96 |
$199,950 |
D/D |
(33,560) |
876,611 |
0 |
% |
|
PACB |
Pacific Biosciences Of Ca... |
See Remarks |
|
2024-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
798,076 |
1,674,687 |
0 |
- |
|
PACB |
Pacific Biosciences Of Ca... |
See Remarks |
|
2024-03-04 |
4 |
S |
$4.87 |
$44,745 |
D/D |
(9,186) |
1,668,826 |
0 |
% |
|
ILMN |
Illumina Inc |
SVP Chief Commercial OfficerOf |
|
2017-05-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
19,056 |
|
- |
|
50 Records found
|
|
Page 2 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|